X’s Cashtags Linked to Wealthsimple, $1B Traded in Two Days

X’s Cashtags generated about $1 billion in global trading in two days; Wealthsimple linked the feature to its Canadian trading platform for iPhone users.

Nikita Bier, X’s head of product, wrote on X on Friday that aggregated data from the company’s trading pilot showed about $1 billion in global trading volume in the two days after the feature launched late Tuesday.

“Based on aggregated data from our trading pilot, X has driven an estimated $1 billion in trading volume globally since launching on Tuesday night,” Bier wrote.

Cashtags let users tap stock tickers and crypto smart contract addresses in posts to view live price charts and recent posts about the asset inside the app. The feature is available to iPhone users in the United States and Canada.

Wealthsimple has connected Cashtags to its Canadian trading platform. When Canadian users tap a Cashtag, the link opens Wealthsimple’s app or web platform so users can place trades. X has not connected Cashtags to any U.S. brokerage.

The Cashtags rollout is part of owner Elon Musk’s effort to add payments and commerce services to X. The company has piloted a peer-to-peer payments product called X Money and showed an external beta in March.

X has obtained money transmitter licenses in more than 40 U.S. states and registered with the Financial Crimes Enforcement Network. The company has not disclosed how crypto payments would work inside X Money.

X reports more than 550 million monthly users. Further broker partnerships, a wider rollout and regulatory details have not been announced.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author